Then, the molecular virtual docking and molecular dynamic simulation results were confirmed that these active compounds and their combinations are expected to exert anti-AD effects by acting on key targets such as STAT3, VEGFA, and MAPK. The gene discussed is STAT3; the disease is Alzheimer disease.